Marsh & McLennan Companies’ fair value estimate remains unchanged at $214.26 per share following the latest analyst commentary and market data. A minor rise in the discount rate along with stability in revenue growth projections underscores a cautious approach amid ongoing sector volatility. Read on to discover how nuanced analyst views shape the current narrative. Learn ways to stay informed about future developments in the stock’s outlook.

Stay updated as the Fair Value for Marsh & McLennan Companies shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Marsh & McLennan Companies.

Recent analyst commentary on Marsh & McLennan Companies reflects both confidence in the firm’s resilience and ongoing caution regarding its valuation and growth prospects. Below, we break out the latest views from the Street.

???? Bullish Takeaways

BofA raised its price target to $246 from $236, citing a relatively calm third quarter for the insurance sector and the absence of major catastrophic events impacting earnings. Despite macroeconomic uncertainties earlier in the year, Marsh & McLennan demonstrated stability in financial results, helping to support a higher price target.

UBS maintains a Buy rating with only a minimal price target reduction to $257 from $258. This underscores continued confidence in the company’s earnings trajectory. The firm highlighted that lighter catastrophe losses across the sector provide upside to earnings estimates.

Analysts continue to credit Marsh & McLennan with relatively strong execution and transparency, even if near-term growth headwinds are acknowledged.

???? Bearish Takeaways

Piper Sandler and Roth Capital each lowered their price targets to $200, with both firms maintaining a Neutral rating. Roth Capital noted that while underlying revenue growth of 4% was in line with their estimate, it likely fell short of broader expectations, and the composition of growth differed from forecasts.

BMO Capital reduced its target to $208 from $222 and highlighted valuation as a key concern, stating the stock "screens as potentially not inexpensive" given current macroeconomic challenges and organic growth underperformance. The firm sees limited near-term upside unless the company demonstrates a stronger growth profile or shifts market perceptions regarding earnings power.

Morgan Stanley trimmed its price target to $215 from $220, citing ongoing headwinds in commercial property and casualty due to pricing slowdowns in both the primary and reinsurance sub-sectors.

On balance, while execution and stability are recognized, multiple analysts perceive valuation as full with limited upside in the absence of a clear catalyst for accelerated growth.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

Marsh McLennan and Bloomberg Media have formed a strategic knowledge partnership to power select Bloomberg Media event properties. The partnership aims to develop and distribute thought leadership at global events and will also showcase the new Marsh brand, which is set to launch worldwide next year.

The company remains focused on growth through acquisitions, prioritizing smaller to midsized deals. These targeted acquisitions are intended to strengthen Marsh & McLennan's presence in underpenetrated markets and are chosen for their strong cultural alignment with the firm.

Marsh & McLennan completed a significant share buyback, repurchasing nearly 2 million shares for $400 million between July and September 2025. Since 2010, the company has bought back over 28 percent of its shares, with a cumulative spend surpassing $12.4 billion.

The discount rate has risen slightly from 6.78% to 6.96%. This indicates a marginal increase in the risk environment used for valuation purposes.

Revenue growth projections remain essentially flat and are holding steady at approximately 5.35%.

Net profit margin projections are unchanged and stay close to 17.64%.

The future P/E ratio has increased modestly from 23.23x to 23.35x. This reflects a minor shift in forward earnings expectations.

The fair value estimate is unchanged at $214.26 per share, which signals stability in overall fundamental assessments.

A Narrative is your personal investment story, connecting where you think Marsh & McLennan Companies is headed, the numbers behind that journey, and its true value. Narratives on Simply Wall St link a company’s outlook, forecasts, and fair value into one clear picture, helping investors decide when to act. Available right on the Community page, Narratives update instantly when the news changes, making them a smarter, easier way to invest.

Read the original Narrative for Marsh & McLennan Companies to stay ahead of the story and see what drives the stock’s outlook:

Get a concise summary of how economic, regulatory, and digital trends will shape Marsh & McLennan’s long-term revenue and earnings growth.

Understand the risks, from pricing headwinds to integration challenges and tech disruption, that could impact future profits and value.

See how new forecasts, price targets, and fair value estimates shift as soon as fresh analyst updates and news break.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include MMC.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com